HRP20201217T1 - Derivati di(fenilpropanoid)glicerola za liječenje raka - Google Patents

Derivati di(fenilpropanoid)glicerola za liječenje raka Download PDF

Info

Publication number
HRP20201217T1
HRP20201217T1 HRP20201217TT HRP20201217T HRP20201217T1 HR P20201217 T1 HRP20201217 T1 HR P20201217T1 HR P20201217T T HRP20201217T T HR P20201217TT HR P20201217 T HRP20201217 T HR P20201217T HR P20201217 T1 HRP20201217 T1 HR P20201217T1
Authority
HR
Croatia
Prior art keywords
cancer
treatment
compound
glycerol derivatives
phenyl propanoid
Prior art date
Application number
HRP20201217TT
Other languages
English (en)
Inventor
Alexander Macgregor
Original Assignee
Alexander Macgregor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alexander Macgregor filed Critical Alexander Macgregor
Publication of HRP20201217T1 publication Critical patent/HRP20201217T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)

Claims (4)

1. Spoj za uporabu u liječenju raka, naznačen time što je spoj formule (Ia): [image] u kojoj: R1 i R2 su neovisno OH, alkoksi ili alkilkarboniloksi, R4 je OH i R6 je H, ili njegova farmaceutski prihvatljiva sol.
2. Spoj prema patentnom zahtjevu 1 za uporabu u liječenju raka, naznačen time što, spoj je najmanje jedan spoj formule: [image] i [image]
3. Farmaceutski pripravak za uporabu u liječenju raka koji sadrži najmanje jedan spoj kako je korišten u bilo kojem od zahtjeva 1 do 2.
4. Spoj formule (IIb) za uporabu u liječenju raka: [image]
HRP20201217TT 2009-10-09 2010-10-08 Derivati di(fenilpropanoid)glicerola za liječenje raka HRP20201217T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25028709P 2009-10-09 2009-10-09
EP10821532.8A EP2486026B1 (en) 2009-10-09 2010-10-08 Derivatives of di(phenylpropanoid) glycerol for the treatment of cancer
PCT/CA2010/001613 WO2011041907A1 (en) 2009-10-09 2010-10-08 Derivatives of di(phenylpropanoid) glycerol for the treatment of cancer

Publications (1)

Publication Number Publication Date
HRP20201217T1 true HRP20201217T1 (hr) 2020-12-11

Family

ID=43352967

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20201217TT HRP20201217T1 (hr) 2009-10-09 2010-10-08 Derivati di(fenilpropanoid)glicerola za liječenje raka

Country Status (20)

Country Link
US (2) US9061993B2 (hr)
EP (1) EP2486026B1 (hr)
JP (1) JP5529280B2 (hr)
CN (1) CN102264713A (hr)
BR (1) BR112012008204A2 (hr)
CA (1) CA2715662C (hr)
CY (1) CY1123161T1 (hr)
DK (1) DK2486026T3 (hr)
ES (1) ES2810906T3 (hr)
HR (1) HRP20201217T1 (hr)
HU (1) HUE051549T2 (hr)
LT (1) LT2486026T (hr)
MX (1) MX360417B (hr)
MY (2) MY160378A (hr)
PL (1) PL2486026T3 (hr)
PT (1) PT2486026T (hr)
RS (1) RS60667B1 (hr)
SI (1) SI2486026T1 (hr)
SM (1) SMT202000428T1 (hr)
WO (1) WO2011041907A1 (hr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8907117B2 (en) * 2011-09-08 2014-12-09 Henry Lowe Anti-tumor and anti-inflammatory dicinnamoyl-glycerol esters and their analogues
US9907786B2 (en) 2014-10-21 2018-03-06 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof
US10092550B2 (en) 2014-10-21 2018-10-09 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof
US20160106722A1 (en) 2014-10-21 2016-04-21 Life Plus, LLC Human therapeutic agents
US12129265B2 (en) 2020-07-21 2024-10-29 Ankh Life Sciences Limited Therapeutic agents and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857873A (en) * 1974-02-11 1974-12-31 Warner Lambert Co 3-hydroxy-5-(3-(substituted-amino)-2-hydroxypropoxy)-benzyl alcohols
CH648753A5 (de) * 1981-07-22 1985-04-15 Givaudan & Cie Sa Lichtschutzmittel.
CN1238333C (zh) * 2003-06-18 2006-01-25 清华大学 药物化合物菠萝酰酯及其制备方法和用途
US7713556B2 (en) * 2006-12-08 2010-05-11 Henry Lowe Anti-tumor and anti-inflammatory extracts of plant biomass and their uses
AU2008205312B2 (en) * 2007-01-08 2013-11-21 Annji Pharmaceutical Co., Ltd. Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and uses thereof
TWI383251B (zh) * 2008-01-16 2013-01-21 Eternal Chemical Co Ltd 感光型聚醯亞胺
KR101074149B1 (ko) * 2009-04-15 2011-10-17 한밭대학교 산학협력단 신규 폴리페놀/폴리페놀 컨쥬게이트 화합물 및 그의 용도
US8907117B2 (en) * 2011-09-08 2014-12-09 Henry Lowe Anti-tumor and anti-inflammatory dicinnamoyl-glycerol esters and their analogues

Also Published As

Publication number Publication date
US10052301B2 (en) 2018-08-21
CY1123161T1 (el) 2021-10-29
ES2810906T3 (es) 2021-03-09
RS60667B1 (sr) 2020-09-30
CA2715662C (en) 2013-05-07
SI2486026T1 (sl) 2020-10-30
JP5529280B2 (ja) 2014-06-25
WO2011041907A1 (en) 2011-04-14
EP2486026A1 (en) 2012-08-15
BR112012008204A2 (pt) 2017-07-18
US20150246014A1 (en) 2015-09-03
MX360417B (es) 2018-10-25
SMT202000428T1 (it) 2020-09-10
PL2486026T3 (pl) 2020-11-02
JP2013507327A (ja) 2013-03-04
US9061993B2 (en) 2015-06-23
EP2486026B1 (en) 2020-06-24
MX2012004160A (es) 2012-09-07
HUE051549T2 (hu) 2021-10-28
CN102264713A (zh) 2011-11-30
EP2486026A4 (en) 2015-07-01
CA2715662A1 (en) 2010-12-14
PT2486026T (pt) 2020-08-21
MY160378A (en) 2017-03-15
MY187188A (en) 2021-09-09
DK2486026T3 (da) 2020-08-17
LT2486026T (lt) 2020-09-10
US20110086912A1 (en) 2011-04-14

Similar Documents

Publication Publication Date Title
CY1124117T1 (el) Ετεροκυκλικες αλκυνυλοβενζολικες ενωσεις και ιατρικες συνθεσεις και χρησεις αυτων
HRP20161103T1 (hr) Kemijski spojevi
HRP20151000T1 (hr) Antivirusni spojevi
MX2010005824A (es) Derivados de aminotiazol.
BRPI0911871A2 (pt) uso de partículas veículo sólidas para melhorar a processabilidade de um agente farmacêutico
ME02666B (me) Cefalosporin sa kateholskom grupom
MA32383B1 (fr) DÉRIVÉS D'INDAZOLES à SUBSTITUTIONS PHÉNYLE ET BENZODIOXYNYLE
SMT201900656T1 (it) Formulazioni di ketorolac pronte all'uso
JO3195B1 (ar) مشتقات أندوليزين جديدة, وطريقة تحضيرهم والتركيبات الصيدلانية التي تحتوي عليهم لعلاج السرطان
PL2036892T3 (pl) Pochodne 1,2,4,5-tetrahydro-3H-benzazepin, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne
SMT201400055B (it) Composti di tioacetato, composizioni e metodi d'uso
BRPI1011952A2 (pt) "composições de combustível compreendendo derivados de isopreno"
BR112013016761A2 (pt) uso de um composto, composto da fórmula, composição farmacêutica, oligonucleotídeo, conjugado de molécula pequena e um oligonucleotídeo, compostos, uso e métodos
HRP20090077A2 (hr) Modulatori farmakokinetičkih svojstava terapeutika
BR112012026951A2 (pt) Compostos de amino-piridazinas úteis na modulação da contratilidade do músculo esquelético, composições farmacêuticas e uso dos compostos
EA201070327A1 (ru) Катехоламиновые производные и их пролекарства
UA109421C2 (uk) Фармацевтична композиція, яка містить ліганди сигма-рецептора
IN2012DN03337A (hr)
DK2041133T3 (da) Derivater af imadazol [1,2-A] pyridine-2-carboxamider, fremstilling deraf og anvendelse deraf i terapeutik
BRPI1009392A2 (pt) "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
HRP20200255T1 (hr) Formulacija ac220 osušena raspršivačem
HRP20201217T1 (hr) Derivati di(fenilpropanoid)glicerola za liječenje raka
DK2040703T3 (da) Derivater af 2-benzoylimidazopyridiner, fremstilling deraf og terapeutisk anvendelse deraf
DE602008000104D1 (de) Neue trizyklische Derivate, ihr Herstellungsverfahren und pharmazeutische Zusammensetzungen, die sie enthalten
SG158091A1 (en) Imidazoazepinone compounds